Neurocrine Biosciences
NBIX
#1452
Rank
$14.85 B
Marketcap
$146.10
Share price
-0.19%
Change (1 day)
2.02%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company